 | NRX Pharmaceuticals, Inc. | |||
| NCM : NRXP || Location: United States | ||||
$3.12+0.07 (+2.3%) |
0.1 M | 3.03 - 3.19 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.511 M |
| March 28, 2024 | 0.425 M |
| March 15, 2024 | 3.714 M |
| Feb. 29, 2024 | 2.714 M |
| Feb. 15, 2024 | 3.868 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.71 | -5.37 | -652.10% |
| 09/30/2023 | -1.16 | -0.70 | 39.45% |
| 06/30/2023 | -1.39 | -1.20 | 13.92% |
| 03/31/2023 | -0.14 | -0.16 | -12.04% |
| 12/31/2022 | -0.15 | -0.16 | -8.18% |
NRXP Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 10.488M | Shares Float | 6.878M |
| Short Float | 0.511M | Market Cap | 29.86M |
| Institution ownership | 3.91% | Insider ownership | 27.414% |
| Earnings Date | 05/14/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -4.00 | Forward EPS | -0.40 |